Novo Holdings completes third investment in Asia in one month

Novo Holdings, which manages the Novo Nordisk Foundation's assets, has invested in an Asian company for the third time in one month. The latest investment was in Esco Lifesciences group.

Photo: Novo Holdings / PR

The owner of Novo Nordisk, Novo Holdings, is lavishing investments on the world's largest continent, most recently through the establishment of an Asian office in Singapore.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs